Market Place
Sourcing Support
Top drugs and pharmaceutical companies of 2019 by revenues
Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-
J&J’s diabetes drug reduces heart risk at the cost of toes; Google’s AI eye doctor initiative
This week in Phispers, we bring you news on J&J’s Invokana, a drug that reduces heart risk
Trump’s comments on drug prices sink pharma stocks; Teva lowers guidance by $ 1 billion
The New
Year began with the JP Morgan Healthcare Conference— the drug industry’s annual
India steps up efforts to improve drug quality; Allergan vows to limit price hikes
This week, Phispers has two news items that demonstrate Indian government’s keenness to improv
